Imaging Technology News

GE HealthCare, Medtronic Integrate Intraoperative Ultrasound System and Surgical Navigation System

tim.hodson — Thu, 09 Apr 2026 16:36:47 +0000

tim.hodson Thu, 04/09/2026 - 11:36

April 9, 2026 — GE HealthCare has announced a digital integration between the GE HealthCare bkActiv intraoperative ultrasound (iUS) system and the Medtronic Stealth AXiS surgical navigation system, which is now commercially available to provide real-time advanced imaging during cranial procedures to complement surgical planning and navigation workflows.

This integration builds on an existing strategic alliance between the companies to accelerate next-generation technology innovation across the enterprise, which extends the relationship between GE HealthCare’s Surgical Innovations and Medtronic.

Now neurosurgeons will be able to incorporate bkActiv as a “plug-and-play” real-time visualization solution during procedures using the Stealth AXiS surgical navigation system without disrupting established workflows. The Stealth AXiS surgical navigation system was recently cleared by the U.S. Food and Drug Administration (FDA) for cranial procedures in the United States, and brings planning, navigation and robotics together into a single, integrated solution to deliver real-time insight in the operating room.

“Real-time visualization is critical for cranial surgical teams to assess anatomy, navigate changes, and make critical decisions in the surgical suite,” said Heidi Seerden, General Manager, Surgical Innovations, GE HealthCare. “We are proud to build on our long-time collaboration with Medtronic to bring together bkActiv with the Stealth AXiS surgical navigation system in a way that supports our shared goals of supporting surgical precision and clinician confidence.”

During cranial procedures, surgeons may encounter “brain shift,” a natural movement or deformation of the brain during surgery that reduces the accuracy of pre-surgical images during the procedure. bkActiv is designed to provide real time visualization that may help clinicians assess anatomy changes such as brain shift by supplying the live iUS image to the Stealth AXiS surgical navigation system, where it can be viewed alongside pre-operative MRI or CT images.

bkActiv also includes features and dedicated software exam types to support visualization and workflow in the neurosurgical suite, including:

Image mirror feature that duplicates the ultrasound image on the scanner’s glass user interface, so surgical staff can see the ultrasound image when the clinical display monitor is turned toward the surgeon
Sensitive color Doppler to visualize blood flow during surgeries
Specialized algorithms to support uniform image resolution and detail around areas of interest
Fully immersible transducers for easy sterilization and single-use needle guides
Transducer Smart Button™ technology that allows the surgeon to freeze, store and print images with one press
A sterilizable remote control that enables the surgeon to control the bkActiv scanner from the sterile field

For more information on bkActiv, visit www.gehealthcare.com/products/ultrasound/surgical-visualization-and-guidance/bkactiv.

Thursday, April 9, 2026 - 11:36

Siemens Healthineers, Onvida Health Sign 10-Year 'Value Partnership'

tim.hodson — Thu, 09 Apr 2026 14:37:49 +0000

tim.hodson Thu, 04/09/2026 - 09:37

April 7, 2026 — Onvida Health and Siemens Healthineers have entered a 10-year Value Partnership¹ designed to bring the latest medical technology to and improve efficiencies across the Onvida health system. As part of the agreement, Siemens Healthineers will modernize Onvida Health’s diagnostic imaging and therapy equipment, and together with its affiliate, ECG Management Consultants (ECG), will work alongside Onvida Health’s leaders to strengthen daily operations and long term planning.

Supporting a Growing Region

Located in Yuma, Ariz., 10 miles from the U.S.-Mexico border and positioned between Phoenix and San Diego, Onvida Health is a unique 430-bed system serving a rapidly evolving community. Yuma is the second-fastest-growing county in Arizona. I

As Yuma’s population continues to rise, so does the need to continue providing advanced medical services close to home. The partnership supports Onvida Health in upgrading key equipment such as computed tomography, magnetic resonance imaging, ultrasound, and radiation therapy systems, helping to reduce wait times and allowing clinical teams to diagnose and treat patients quickly and accurately.

“As a leading rural, regional health system, Onvida Health values the importance of investing in technology today, and the impact it has on healthcare tomorrow,” says Robert J. Trenschel, DO, president and CEO at Onvida Heath. “Partnerships like this build on our ongoing commitment to providing our patients the same level of advanced, innovative technology often reserved for major metropolitan areas.”

Some of the partnership highlights include:

Continuous Access to the Latest Technology: Patients will benefit from Siemens Healthineers' advanced imaging and treatment tools, improving early detection and helping care teams provide more personalized care.
Enhanced Clinical Capabilities: A coordinated plan for both technology and service will help advance care in areas such as heart health, cancer treatment, and diagnostic imaging, supporting Onvida Health’s long-term vision for growth.
A Long-term Commitment: Siemens Healthineers and ECG will partner with Onvida Health on strategic planning to help address challenges including workforce shortages and patient scheduling.

“By focusing on improvements in rural health and quality of care in rapidly growing communities, Onvida Health and Siemens Healthineers are combining local expertise and commitment with the advanced technology and insights we’ve developed by collaborating with providers around the world,” said John Kowal, president and head of the Americas at Siemens Healthineers. Added Chris Collins, CEO of ECG: “This unique partnership brings together advanced medical technology and systemwide advisory expertise to help Onvida Health accelerate performance, scale innovation, and further strengthen their position as a market leader.”

Further information is available at www.siemens-healthineers.com.

Value Partnerships are long-term and comprehensive engagements between Siemens Healthineers and healthcare providers, enabling them to create more value to better treat patients and reduce operational complexity. They combine each healthcare provider’s know-how and strategic goals with the technologies, innovations and industry expertise of Siemens Healthineers to address pressing challenges such as workforce and budgetary constraints and enhancing healthcare access in underserved communities.

Thursday, April 9, 2026 - 09:37

Alpha Imaging Intelli-C R/F System Designed for GI Imaging

tim.hodson — Wed, 08 Apr 2026 20:35:52 +0000

tim.hodson Wed, 04/08/2026 - 15:35

April 8, 2026 — Alpha Imaging, a Radon Medical Imaging company, will display its latest advancement in image-guided endoscopy at Digestive Disease Week 2026 (DDW), May 2-5, in Chicago, Illinois.

The Intelli-C is a tilting radiographic/fluoroscopic (R/F) system engineered to deliver low-dose, high-quality imaging tailored to the demands of the gastrointestinal imaging market. Designed with the requirements of GI suites in mind, the system supports image-guided endoscopic procedures — including ERCP and advanced therapeutic procedures — giving gastroenterologists a dedicated imaging solution that can improve procedural efficiency and patient outcomes.

“This system was purpose-built for GI imaging, and we believe it will meaningfully change how facilities approach image-guided endoscopy — delivering clinical confidence while helping reduce radiation exposure for patients and staff alike. We’re looking forward to putting it in front of the people who will benefit most from it,” said Jimmy Entinger, Director of Channel Sales at Alpha Imaging.

Alpha Imaging will be exhibiting at Booth 5142 at DDW.

To learn more about the Intelli-C, go to https://alpha-imaging.com.

Wednesday, April 8, 2026 - 15:35

Nanox Signs Regional Distribution Agreement with Integrity Medical Service

tim.hodson — Wed, 08 Apr 2026 18:11:35 +0000

tim.hodson Wed, 04/08/2026 - 13:11

April 2, 2026 — Nano-X Imaging Ltd. recently announced its U.S.-based subsidiary, Nanox Impact Inc., has signed a new distribution agreement with Integrity Medical Service Inc., a Colorado based provider of imaging solutions serving hospitals, orthopedic practices, imaging centers and outpatient providers.

Under the terms of the agreement, Integrity Medical Service will lead sales, implementation and service support for the Nanox.ARC system throughout Colorado, Wyoming and the western parts of Kansas and Nebraska.

The collaboration is expected to expand Nanox’s presence in the region while leveraging Integrity’s established relationships within the local imaging community. The target will be to deploy four systems in Year 1 and 12 in Year 2, subject to market conditions and customer adoption.

Integrity Medical Service operates with a service driven model supported by a dedicated team of field service engineers, enabling ongoing customer support, system uptime, and clinical continuity. This infrastructure positions the company to support efficient deployment and long-term use of advanced imaging solutions across outpatient settings.

The agreement supports Nanox’s broader strategy of partnering with regional distributors that combine commercial reach with strong service capabilities to drive adoption and sustained utilization.

For more information, please visit www.nanox.vision.

Wednesday, April 8, 2026 - 13:11

Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2026 Annual Meeting

tim.hodson — Tue, 07 Apr 2026 21:21:04 +0000

tim.hodson Tue, 04/07/2026 - 16:21

Event Date

Sat, 05/30/2026 - 12:00 - Tue, 06/02/2026 - 12:00

Location

Los Angeles, California

SNMMI 2026

Los Angeles to Host SNMMI 2026

tim.hodson — Tue, 07 Apr 2026 21:05:18 +0000

tim.hodson Tue, 04/07/2026 - 16:05

The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) 2026 Annual Meeting will take place May 30–June 2 in Los Angeles, California.

SNMMI brings together global leaders to present the latest research and advances shaping clinical care in nuclear medicine, molecular imaging and theranostics.

The meeting will feature:

New research in theranostics and oncology, cardiology and neuroscience
New developments in imaging technology and instrumentation
Clinical applications impacting diagnosis, treatment, and patient management
A sold-out exhibit hall highlighting the latest innovations

Click here to access the entire conference agenda.

Tuesday, April 7, 2026 - 16:05

Catalyst MedTech Establishes Full Access Neurology Solution for Brain PET Implementation in the U.S.

tim.hodson — Mon, 06 Apr 2026 16:20:30 +0000

tim.hodson Mon, 04/06/2026 - 11:20

March 25, 2026 — Catalyst MedTech, a provider of nuclear medicine and molecular imaging solutions, has announced it is continuing the national deployment of its Full Access Neurology solution — positioning the company as the definitive partner for implementing Brain PET imaging programs across the United States.

As momentum builds around biomarker-driven diagnosis in Alzheimer’s disease and other neurodegenerative conditions, the industry is reaching an inflection point. While new entrants and recent announcements highlight growing interest in dedicated brain imaging, the primary barrier remains unchanged: access to scalable, operational imaging solutions.

From Technology to Implementation

The emergence of dedicated Brain PET systems has reinforced what the industry already knows — advanced imaging is essential to diagnosis, therapy eligibility, and disease monitoring. However, technology alone does not solve the problem.

Catalyst MedTech’s Full Access Neurology solution is designed to operationalize Brain PET at scale — enabling neurology practices, health systems, imaging providers and clinical research sites to bring advanced imaging in-house without the traditional barriers of capital, staffing and infrastructure.

The platform integrates:

Optimized, dedicated Brain PET technology powered by CareMiBrain
Quantification and clinical workflow integration
Nationwide service, support, and maintenance
Flexible deployment models to enable rapid adoption

A Proven Model

Catalyst MedTech brings more than 26 years of experience implementing advanced imaging programs across nuclear cardiology — where the company has successfully expanded access nationwide through similar deployment models.

That same approach is now being applied to neurology.

Catalyst MedTech delivers a complete solution — combining equipment, service, clinical integration and operational support into a single, scalable model.

The Next Phase of Alzheimer’s Care

Recent developments, including the launch of dedicated Brain PET clinics in the U.S., reflect growing demand for infrastructure to support biomarker-driven diagnosis. These clinics are incorporating CareMiBrain, supported by Catalyst MedTech’s Full Access Neurology solution, to enable broader clinical adoption of optimized, dedicated Brain PET.

These developments underscore a critical shift - The market is no longer asking if Brain PET is needed—it is asking how to implement it.

Catalyst MedTech is answering that question.

Through Full Access Neurology, the company is enabling:

Earlier, more accurate diagnosis through biomarker-based imaging
Improved patient access to advanced diagnostic tools
Standardized imaging protocols for clinical care and research
Scalable infrastructure to support growing demand for neuroimaging

“Today’s neurology care is to be defined by equitable access to advanced imaging for earlier diagnosis and more confident care decisions across Alzheimer’s disease and other neurologic conditions, including Lewy body dementia, frontotemporal dementia, brain tumors, chronic traumatic encephalopathy (CTE), and psychiatric disorders,” said Martin Shirley, President and CEO at Catalyst MedTech. “The availability of FDG, amyloid-targeting agents, and emerging tau-targeting agents amplifies the need to create access through advanced technology, proven clinical models, and new workflows from a single source. At Catalyst MedTech, our 26-year track record has proven that innovation only matters when it reaches the people who need it. Through Full Access Neurology, we’re elevating Brain PET from a specialized resource to an accessible standard of care—giving patients and their care teams the insight required to make confident, timely decisions.”

For more information, please visit https://catalystmedtech.com/

Monday, April 6, 2026 - 11:20

FDA Grants 510(k) Clearance to GE HealthCare's True Definition DL Software

tim.hodson — Fri, 03 Apr 2026 15:14:05 +0000

tim.hodson Fri, 04/03/2026 - 10:14

April 2, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for True Definition DL², the latest addition to its portfolio of deep learning image reconstruction solutions for computed tomography (CT). Designed to deliver crisp, high-resolution images with exceptional sharpness, True Definition DL builds on the company’s TrueFidelity DL and True Enhance DL technologies — helping support fast scans and broader coverage across pulmonary, musculoskeletal and inner ear imaging.

“Image quality matters in healthcare — because when imaging performance is aligned with the specific diagnostic task, it plays a critical role in improving accuracy, enabling earlier detection, and guiding appropriate patient care,” shares Chad Rowland, Executive Director, Global Premium CT and Photon Counting, GE HealthCare. “For clinicians, diagnostic confidence begins with the ability to clearly visualize subtle structures, differentiate tissues, and trust what is seen on the screen. For patients, that clarity can translate into quicker answers, fewer repeat scans and care plans tailored to their specific needs. With new tools like deep learning at our disposal, the industry has entered a new era in which reconstruction methods are more accessible to a broad range of providers, delivering sharp, consistent images and enabling care teams to make timely, well-informed decisions that directly impact patient outcomes.”

As chronic diseases continue to rise worldwide³, the demand for fast, precise imaging is accelerating. The cancer burden alone is projected to increase by over 75 percent by 2050⁴, while cardiovascular disease prevalence is expected to rise by nearly 90 percent — driven by aging populations and rising risk factors⁵ — placing unprecedented pressure on clinicians and diagnostic systems for early detection.

Imaging sits at the center of modern care, with billions of diagnostic imaging exams performed globally each year, and volumes continuing to rise as demand for earlier detection and disease management grows.⁶ Increasingly, deep learning is transforming how these images are reconstructed and interpreted. By harnessing advanced neural networks and high-performance computing, DL enables sharper images, improved detectability, and faster processing compared to traditional approaches.

GE HealthCare helped pioneer this shift with the introduction of TrueFidelity DL for whole‑body imaging in 2019 – the industry’s first deep learning–based image reconstruction technology⁷ — and later expanded the solution to support high‑definition gated cardiac scan modes, designed to sharpen the vessel lumen and enhance contrast‑rich structures. Today, innovations like True Definition DL continue to advance what’s possible by delivering consistently high‑quality images at the speed clinicians need for confident decision‑making — enhancing spatial resolution in high‑contrast regions, including bone (such as the inner ear) and lung imaging.

The Power of Deep Learning

High-resolution imaging is especially critical in areas like lung and musculoskeletal care, where detecting subtle structures can significantly impact outcomes. Yet historically, improving image detail has required trade-offs, including higher radiation dose, longer scan times, or limited coverage. Newer technologies such as photon counting CT hold promise, but broad access to scalable, AI-driven advancements like deep learning are increasingly important as imaging demands grow.

True Definition DL helps overcome these limitations by delivering exceptional clarity in high resolution CT imaging for bone and lung without compromising dose efficiency or acquisition speed. Its DL–driven approach enhances spatial resolution across multiple directions, integrates artifact suppression, and supports high definition (HD) mode to improve the visibility of fine anatomical structures such as small airways, pulmonary nodules, and trabecular bone patterns. This enhancement is critical for high-contrast imaging tasks, particularly in bone and lung imaging, where diagnostic confidence hinges on the ability to resolve subtle details.

Additionally, the solution offers a 1024 matrix for high resolution display, and chest imaging achievable in under one second, empowering clinicians to see more, diagnose with greater confidence, and expand access to high resolution imaging performance across a broader range of clinical settings.

“True Definition DL delivers exceptional spatial resolution for visualizing very small anatomical structures,” shares Dr. Stefanie Bitschnau, radiologist and collaborator at Radiomed. “In chest imaging, this level of detail is particularly valuable for assessing small airways, supporting earlier and more confident evaluation of interstitial lung disease. Additionally, the technology is highly beneficial in applications such as inner ear imaging with petrous bone scans, where it allows us to clearly visualize the auditory ossicles and detect erosions at an early stage. This improved definition also supports more confident fracture assessment.”

Deep Learning for CT

True Definition DL joins the company’s extended deep learning portfolio for CT — including TrueFidelity DL and True Enhance DL – which leverages dedicated Deep Neural Networks (DNN) for image reconstruction, offering clinicians around the world improved images with better detail and quality for critical insights.

TrueFidelity DL overcomes traditional trade-offs in CT imaging – reducing noise while preserving natural image texture and sharpness during both single and dual energy imaging. The result is high-definition images that avoid the over-smoothed or artificial appearance of conventional methods, enabling preferred image sharpness⁸low-contrast image quality performance and preferred noise texture, at the same dose.

This approach has had a meaningful clinical impact, improving diagnostic confidence across a wide range of applications, from head and cardiac imaging to ultra-low-dose chest and abdominal exams. Backed by extensive global research, TrueFidelity DL enables clinicians to achieve consistent image quality at lower doses, supporting better decision-making and patient care without compromise.

Additionally, GE HealthCare developed True Enhance DL to deliver improved contrast from standard single-energy CT scans, helping clinicians visualize critical anatomy with greater clarity. By using a dedicated deep neural network trained on GSI (Gemstone Spectral Imaging) monochromatic images to estimate 50 keV results – typically only achievable with dual-energy systems – True Enhance DL brings the proven benefits of GSI into single-energy imaging.

This approach enhances contrast while maintaining high image quality and accuracy, combining the strengths of GSI with advanced AI. The solution also integrates seamlessly into existing workflows and offers multiple models tailored to different clinical tasks, enabling more confident diagnoses across a range of applications.

Altogether, GE HealthCare’s ongoing investment in deep learning technologies – available on the Revolution Apex platform and Revolution™ Vibe for both in-field CT upgrades and new installations – supports its vision of expanding access to AI-enabled imaging across diverse care settings. By equipping facilities with fast, high-quality imaging solutions, the company aims to help healthcare providers reduce patient backlogs, increase exam capacity, and deliver more personalized care – while enabling clinicians to make fast, confident diagnoses that improve patient outcomes.

For more information on GE HealthCare’s CT portfolio, including its deep learning solutions, visit gehealthcare.com.

Durlach, P. Stat. "Almost Every Patient Story Starts with an Image." February 14, 2022. www.statnews.com/sponsor/2022/02/14/almost-every-patient-story-starts-with-an-image/.
True Definition DL is 510(k) cleared with the U.S. FDA. Not CE Marked. Not available for sale in all regions.
Feigin VL, Vos T, Nichols E, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19(3):255-265. doi:10.1016/S1474-4422(19)30411-9.
World Health Organization. “Global Cancer Burden Growing, Amidst Mounting Need for Services.” February 1, 2024. www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services.
Chong, Bryan, Jayanth Jayabaskaran, Silingga Metta Jauhari, Siew Pang Chan, Rachel Goh, Martin Tze Wah Kueh, Henry Li, Yip Han Chin, Gwyneth Kong, Vickram Vijay Anand, et al. “Global Burden of Cardiovascular Diseases: Projections from 2025 to 2050.” European Journal of Preventive Cardiology 32, no. 11 (August 2025): 1001–1015. https://doi.org/10.1093/eurjpc/zwae281.
Read My MRI. “How Many Medical Imaging Scans Are Done Per Year? MRI, CT, PET, Ultrasound & X-Ray Statistics.” March 2, 2025. https://readmymri.com/blog/how-many-medical-imaging-scans-are-done-per-year?utm_source=chatgpt.com.
TrueFidelity/deep learning image reconstruction r receives the first FDA 510(k) clearance in April 2019. https://gehealthcare.ent.box.com/file/1815918747694.
Based on the peer-reviewed evidence summary of TrueFidelity

Friday, April 3, 2026 - 10:14

Premier Radiology Services to Acquire Teleradiology Group

tim.hodson — Fri, 03 Apr 2026 15:13:00 +0000

tim.hodson Fri, 04/03/2026 - 10:13

April 1, 2026 — Premier Radiology Services has acquired Global Imaging Solutions (GLOBIS), a leading teleradiology group providing subspecialty imaging interpretations to outpatient imaging centers and orthopedic practices. The addition of GLOBIS further expands Premier’s subspecialized capabilities and strengthens its ability to support advanced diagnostic imaging needs nationwide.

“Welcoming the GLOBIS team marks another exciting step for Premier, bringing a talented group of fellowship-trained radiologists, an expanded client base, and a dedicated support team. Together, these strengths enhance our platform and position us to meet the growing demand for high-quality teleradiology services in outpatient imaging,” said Andy Copilevitz, CEO of Premier.

Both Premier and GLOBIS were founded by radiologists and built to support radiologists, reflecting a shared commitment to physician autonomy, clinical excellence, and high-quality radiology services. Through this combination, the GLOBIS team will gain access to Premier’s advanced technology platform, expanded administrative infrastructure, and collaborative clinical environment, enhancing the organization’s ability to deliver precise, reliable imaging services to healthcare providers and the patients they serve.

“At GLOBIS, we have always believed in providing imaging solutions that go beyond service to create a personal connection with our clients,” said Jack Considine, M.D., CEO and Co-Founder of GLOBIS. “This acquisition is a testament to the dedication and hard work of our team, and I am confident that Premier will continue to advance our mission by combining strengths and expanding our reach to deliver exceptional service.”

Dr. Considine and his team will join Premier following the acquisition, ensuring continuity for GLOBIS’ customers and physicians, and further strengthening Premier’s operations and clinical talent.

For more information, please visit https://premierradiologyservices.com.

Friday, April 3, 2026 - 10:13

QT Imaging Releases Next Generation of Breast Imaging Software

tim.hodson — Thu, 02 Apr 2026 17:32:55 +0000

tim.hodson Thu, 04/02/2026 - 12:32

April 1, 2026 — QT Imaging Holdings has released its latest image reconstruction software update, version 4.5.0. This next-generation software improves spatial resolution in reflection imaging by implementing optimized, spatially varying deconvolution during reflection image reconstruction, resulting in more accurate image representation while maintaining efficient processing times.

Version 4.5.0 also introduces enhanced reflection images generated through the fusion of speed of sound and reflection data, providing clinicians and researchers with improved visualization and more comprehensive tissue characterization information. These enhancements are designed to improve image interpretation and support comprehensive and reproducible analysis across a wide range of cases.

"The enhanced reflection images represent a meaningful improvement in image quality and usability. Combining reflection with speed of sound information provides additional insight that was not previously available from reflection imaging alone," said Dr. John Tentinger, President and Chief Executive Officer at Innovative Radiology, a radiology center in West Des Moines, Iowa, and a QT Imaging customer.

In addition, the 4.5.0 release includes improved image reconstruction for small breasts and the implementation of more accurate assessment of fibroglandular tissue composition in breasts with implants, addressing important clinical scenarios and expanding the software’s usability across a broader range of patient anatomies.

“Building on our multimodal imaging approach, we are advancing the development of attenuation as an additional quantitative biomarker, to complement speed of sound and reflection intensity. The integration of attenuation is expected to further enhance tissue characterization capabilities and provide clinicians and researchers with additional quantitative information for improved analysis and decision support," said Dr. James Wiskin, QT Imaging Fellow.

These advancements reflect QT Imaging’s continued focus on improving image quality, clinical reliability, and workflow efficiency, and represent another important step in the company’s ongoing development of advanced imaging software solutions.

Please visit the company’s website at www.qtimaging.com for additional information.

Thursday, April 2, 2026 - 12:32